Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Istanbul University-Cerrahpaşa

InstitutionResearch output, impact & collaborations

Istanbul University-Cerrahpaşa is a research organisation in Istanbul, TR. OpenAlex records 27,995 works and 719,594 citations for it. 8,484 researchers list it as their most recent affiliation.

27,995
Works
719,594
Citations
8,484
Researchers
36
Avg h-index

How has Istanbul University-Cerrahpaşa's publication output changed over time?

ScholarIQpublication output · 2010–2021

Output grew50% over the shown period — from 2 works in 2010 to 3 in 2021.

2
2
1
2
2
3
201020172018201920202021

Who are the most-cited researchers behind Istanbul University-Cerrahpaşa?

ScholarIQtop researchers by citations
1
Beyhan Tüysüz · Connective tissue disorders research
258 works7,745 citations
2
Deniz Palamar · Peripheral Nerve Disorders
71 works704 citations
3
Ali Şeker · Bone fractures and treatments
104 works684 citations
4
Seha Saygılı · Renal Diseases and Glomerulopathies
115 works637 citations
5
Dilek Uludağ Alkaya · Connective tissue disorders research
53 works380 citations

What are the most-cited papers on Istanbul University-Cerrahpaşa?

ScholarIQmost cited works
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Catherine Wadsworth, Giovanni Melillo, Haiyi Jiang, Yifan Huang, Phillip A. Dennis, Mustafa Özgüroğlu
New England Journal of Medicine. 20174,592 CitationsOPEN ACCESS
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu, Steinbjørn Hansen, Jean-Pascal Machiels, Ivo Kocák, Gwénaëlle Gravis, I. Bodrogi, Mary J. MacKenzie, Liji Shen, Martin Roessner, Sunil Gupta, Oliver Sartor
The Lancet. 20103,299 Citations
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Corinne Faivre‐Finn, Martin Reck, Johan Vansteenkiste, David R. Spigel, Catherine Wadsworth, Giovanni Melillo, Maria Taboada, Phillip A. Dennis, Mustafa Özgüroğlu
New England Journal of Medicine. 20182,828 CitationsOPEN ACCESS
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi, NamPhuong Tran, Luis Fein, Nobuaki Matsubara, A. Rodrı́guez-Antolı́n, B. Yа. Alekseev, Mustafa Özgüroğlu, Dingwei Ye, Susan Feyerabend, Andrew Protheroe, Peter De Porre, Thian Kheoh, Youn C. Park, Mary B. Todd, Kim N.
New England Journal of Medicine. 20172,266 CitationsOPEN ACCESS
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
Roy S. Herbst, Giuseppe Giaccone, Filippo de Marinis, Niels Reinmuth, A. Vergnenègre, Carlos H. Barrios, Masahiro Morise, Enriqueta Felip, Zoran Andrić, Sarayut Lucien Geater, Mustafa Özgüroğlu, Wei Zou, Alan Sandler, Ida Enquist, Kimberly M. Komatsubara, Yu Deng, Hiroshi Kuriki, Xiaohui Wen, Mark L. McCleland, Simonetta Mocci, Jacek Jassem, David R. Spigel
New England Journal of Medicine. 20201,714 CitationsOPEN ACCESS

How much of the research on Istanbul University-Cerrahpaşa is open access?

ScholarIQopen access share
92%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
17%
Bronze
58%
Closed
8%

Related on ScholarIQ

Ocular Diseases and Behçet’s Syndrome
Top Topic
Education Practices and Challenges
Top Topic
Autoimmune and Inflammatory Disorders Research
Top Topic
Inflammasome and immune disorders
Top Topic
COVID-19 Clinical Research Studies
Top Topic
COVID-19 and Mental Health
Top Topic
470M+ articles · free account